C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 215/52 (2006.01) A61K 31/47 (2006.01) A61P 3/04 (2006.01) A61P 11/06 (2006.01) A61P 25/00 (2006.01) A61P 25/18 (2006.01) A61P 25/22 (2006.01) A61P 25/24 (2006.01) A61P 25/28 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2613001
Compounds of Formula I wherein R1, A, R2, R3, R4, R5 n, m and q are as described in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.
La présente invention décrit des composés de Formule I où R1, A, R2, R3, R4, R5, n, m et q sont tels que définis dans la description de l'invention, des sels de qualité pharmaceutique, des méthodes de fabrication, des préparations pharmaceutiques contenant lesdits composés ainsi que leurs méthodes d'utilisation.
Albert Jeffrey S.
Alhambra Cristobal
Kang James
Koether Gerard M.
Li Yan
Astrazeneca Ab
Mccarthy Tetrault Llp
LandOfFree
Quinoline 3 -sulfonate esters as nk3 receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline 3 -sulfonate esters as nk3 receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline 3 -sulfonate esters as nk3 receptor modulators will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1839623